Developments and innovations in drugs and devices have helped heart patients receive better and effective treatment, however lack of awareness and poor accessibility continue to be major roadblocks in reducing disease prevalence.
Coupled with new technological advancements, biopharmaceutical innovation has brought a new era of medicine which has transformed the way we research and develop new medicines to benefit heart patients. New medical discoveries and technologies, and payment incentives have slashed the time it takes to treat and manage the heart diseases. With rapidly changing norms and situations, now we have the solutions to cure even the most challenging heart diseases.